Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Stoppa-Lyonnet

Showing results (51-60 of 124) with videos related to

Pageof 13
Sort By:
Lancet (London, England)|May 29, 1993
Screening of inherited breast cancer with DNA markersP Lalle, Y J Bignon, D Stoppa-Lyonnet, et al.
Bulletin Du Cancer|October 1, 1993
[Hereditary predisposition for cancer of the breast and the ovary]P Lalle, D Stoppa-Lyonnet, S Mazoyer, et al.
Cancer Research|February 1, 1996
Germ line mutation at BRCA1 affects the histoprognostic grade in hereditary breast cancerF Eisinger, D Stoppa-Lyonnet, M Longy, et al.
American Journal of Human Genetics|January 23, 1999
An Alu-mediated 6-kb duplication in the BRCA1 gene: a new founder mutation?N Puget, O M Sinilnikova, D Stoppa-Lyonnet, et al.
Journal of Medical Genetics|November 5, 2002
Bar code screening on combed DNA for large rearrangements of the BRCA1 and BRCA2 genes in French breast cancer familiesS Gad, M Klinger, V Caux-Moncoutier, et al.
Human Molecular Genetics|March 21, 1998
Prevalence of p16 and CDK4 germline mutations in 48 melanoma-prone families in France. The French Familial Melanoma Study GroupN Soufir, M F Avril, A Chompret, et al.
Journal of Medical Genetics|May 16, 2002
A T to C mutation in the polypyrimidine tract of the exon 9 splicing site of the RB1 gene responsible for low penetrance hereditary retinoblastomaS H Lefévre, L Chauveinc, D Stoppa-Lyonnet, et al.
Disease Markers|December 14, 1999
Risk estimation as a decision-making tool for genetic analysis of the breast cancer susceptibility genes. EC Demonstration Project on Familial Breast CancerJ Chang-Claude, H Becher, M Caligo, et al.
British Journal of Cancer|October 25, 2000
Low expression of bcl-2 in Brca1-associated breast cancersP Freneaux, D Stoppa-Lyonnet, E Mouret, et al.
Genomics|January 25, 2000
Denaturing high-performance liquid chromatography detects reliably BRCA1 and BRCA2 mutationsT Wagner, D Stoppa-Lyonnet, E Fleischmann, et al.
Pageof 13

Showing results (51-60 of 124) with videos related to

Sort By:
Pageof 13
Lancet (London, England)|May 29, 1993
Screening of inherited breast cancer with DNA markersP Lalle, Y J Bignon, D Stoppa-Lyonnet, et al.
Bulletin Du Cancer|October 1, 1993
[Hereditary predisposition for cancer of the breast and the ovary]P Lalle, D Stoppa-Lyonnet, S Mazoyer, et al.
Cancer Research|February 1, 1996
Germ line mutation at BRCA1 affects the histoprognostic grade in hereditary breast cancerF Eisinger, D Stoppa-Lyonnet, M Longy, et al.
American Journal of Human Genetics|January 23, 1999
An Alu-mediated 6-kb duplication in the BRCA1 gene: a new founder mutation?N Puget, O M Sinilnikova, D Stoppa-Lyonnet, et al.
Journal of Medical Genetics|November 5, 2002
Bar code screening on combed DNA for large rearrangements of the BRCA1 and BRCA2 genes in French breast cancer familiesS Gad, M Klinger, V Caux-Moncoutier, et al.
Human Molecular Genetics|March 21, 1998
Prevalence of p16 and CDK4 germline mutations in 48 melanoma-prone families in France. The French Familial Melanoma Study GroupN Soufir, M F Avril, A Chompret, et al.
Journal of Medical Genetics|May 16, 2002
A T to C mutation in the polypyrimidine tract of the exon 9 splicing site of the RB1 gene responsible for low penetrance hereditary retinoblastomaS H Lefévre, L Chauveinc, D Stoppa-Lyonnet, et al.
Disease Markers|December 14, 1999
Risk estimation as a decision-making tool for genetic analysis of the breast cancer susceptibility genes. EC Demonstration Project on Familial Breast CancerJ Chang-Claude, H Becher, M Caligo, et al.
British Journal of Cancer|October 25, 2000
Low expression of bcl-2 in Brca1-associated breast cancersP Freneaux, D Stoppa-Lyonnet, E Mouret, et al.
Genomics|January 25, 2000
Denaturing high-performance liquid chromatography detects reliably BRCA1 and BRCA2 mutationsT Wagner, D Stoppa-Lyonnet, E Fleischmann, et al.
Pageof 13